Cardiovascular Therapeutics

Scope & Guideline

Empowering Global Access to Cardiovascular Discoveries

Introduction

Delve into the academic richness of Cardiovascular Therapeutics with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1755-5914
PublisherWILEY-HINDAWI
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2008 to 2024
AbbreviationCARDIOVASC THER / Cardiovasc. Ther.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON WIT 5HE, ENGLAND

Aims and Scopes

Cardiovascular Therapeutics aims to advance the field of cardiovascular medicine through innovative research, clinical trials, and therapeutic advancements. The journal focuses on a wide range of topics related to cardiovascular diseases, therapies, and health outcomes, providing a platform for researchers and clinicians to share their findings.
  1. Cardiovascular Risk Assessment and Management:
    The journal publishes studies focusing on the assessment of cardiovascular risk factors, including novel biomarkers and risk prediction models, to enhance the management and prevention of cardiovascular diseases.
  2. Therapeutic Interventions and Clinical Trials:
    A significant emphasis is placed on clinical trials evaluating the efficacy and safety of new therapeutic interventions, including pharmacological treatments, surgical procedures, and lifestyle modifications.
  3. Pathophysiology and Mechanistic Insights:
    Research articles delve into the underlying mechanisms of cardiovascular diseases, exploring cellular and molecular pathways that contribute to conditions such as myocardial infarction, heart failure, and atherosclerosis.
  4. Rehabilitation and Exercise Therapy:
    The journal highlights studies that assess the role of rehabilitation strategies, including exercise therapy and lifestyle interventions, in improving outcomes for patients with cardiovascular conditions.
  5. Emerging Therapies and Natural Products:
    There is a growing interest in the exploration of natural products and alternative therapies for cardiovascular diseases, with studies investigating their potential therapeutic roles and mechanisms of action.
  6. Public Health and Epidemiological Studies:
    Cardiovascular Therapeutics also prioritizes research addressing public health aspects, epidemiological trends, and the socioeconomic impact of cardiovascular diseases.
Recent publications in Cardiovascular Therapeutics have highlighted several trending and emerging themes that reflect the evolving landscape of cardiovascular research. These themes are gaining traction and may represent future directions for the field.
  1. Biomarkers for Cardiovascular Diseases:
    An increasing number of studies focus on identifying and validating novel biomarkers for cardiovascular diseases, particularly in heart failure and atherosclerosis, which can enhance early diagnosis and treatment.
  2. Impact of COVID-19 on Cardiovascular Health:
    Research examining the implications of COVID-19 on cardiovascular health, including the effects of viral infections on existing cardiovascular conditions, has surged, showcasing the pandemic's influence on cardiovascular research.
  3. Integrative and Holistic Approaches to Treatment:
    Emerging interest in integrative therapies, such as meditation, yoga, and lifestyle modifications, reflects a trend towards holistic approaches to cardiovascular health, emphasizing the importance of mental and physical well-being.
  4. Advanced Imaging Techniques and Diagnostics:
    There is a notable trend towards the utilization of advanced imaging techniques for better diagnosis and management of cardiovascular diseases, facilitating more precise interventions.
  5. Artificial Intelligence and Machine Learning in Cardiovascular Research:
    The application of AI and machine learning methods in cardiovascular research is rapidly growing, particularly in risk prediction models and personalized treatment strategies, marking a significant technological advancement in the field.

Declining or Waning

While the journal continues to explore a wide array of cardiovascular topics, certain themes appear to be declining in prominence. This may reflect shifts in research focus or advancements in understanding that have led to reduced interest in specific areas.
  1. Traditional Risk Factor Studies:
    Research focusing solely on traditional cardiovascular risk factors, such as hypertension and hyperlipidemia, has decreased as newer methodologies and biomarkers gain traction in risk assessment.
  2. Pharmacogenomics in Cardiovascular Therapy:
    There has been a waning interest in studies solely dedicated to pharmacogenomic profiling for cardiovascular drug responses, possibly due to advancements in personalized medicine that integrate broader genetic and environmental factors.
  3. Basic Science Studies without Clinical Relevance:
    The journal has seen fewer submissions of basic science studies that do not translate into clinical applications, indicating a preference for research with direct implications for patient care.

Similar Journals

Cardiology in Review

Pioneering reviews that shape cardiovascular care.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1061-5377Frequency: 6 issues/year

Cardiology in Review, published by Lippincott Williams & Wilkins, is a prominent journal focused on advancing the field of cardiology and cardiovascular medicine. With a history of publication spanning from 1995 to 2024, the journal serves as an essential resource for researchers, healthcare professionals, and students alike, offering in-depth reviews and analyses on the latest developments, clinical practices, and research findings in cardiology. Despite being a traditional print journal, it maintains a commendable Q2 ranking in both cardiology and miscellaneous medicine categories as of 2023, reflecting its influence and rigor in the academic community, with a Scopus rank of #132 out of 387 in its field, placing it in the 66th percentile. The journal aims to bridge the gap between clinical practice and emerging research, promoting a deeper understanding and integration of innovative strategies in cardiovascular care. With its commitment to high-quality scholarship, Cardiology in Review remains a vital conduit for knowledge and dialogue within the evolving landscape of cardiovascular health.

CURRENT CARDIOLOGY REVIEWS

Fostering Collaboration for Enhanced Patient Care
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-403XFrequency: 4 issues/year

CURRENT CARDIOLOGY REVIEWS, an esteemed journal published by BENTHAM SCIENCE PUBL LTD, is a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1573-403X and E-ISSN of 1875-6557, this journal presents comprehensive reviews that contribute significantly to the advancement of scientific knowledge and clinical practices in cardiology. Operating with open access options, CURRENT CARDIOLOGY REVIEWS is dedicated to bridging the gap between research and practice, thereby encouraging interdisciplinary collaboration and knowledge sharing. The journal has been instrumental in disseminating high-impact findings, consistently maintaining a Q2 category ranking in both Cardiology and Cardiovascular Medicine, as well as within the miscellaneous categories of Medicine, highlighting its relevance and respect in the academic community. Researchers, practitioners, and students alike will find valuable insights into contemporary cardiovascular issues, practices, and innovations that promote better patient outcomes. Based in the United Arab Emirates, CURRENT CARDIOLOGY REVIEWS encourages global contributions and reflects the latest advancements up to the year 2024, solidifying its role as an essential publication for those engaged in the quest for excellence in cardiovascular health.

International Heart Journal

Connecting Researchers to Enhance Cardiovascular Care
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

PROGRESS IN CARDIOVASCULAR DISEASES

Advancing the Frontiers of Cardiovascular Medicine
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0033-0620Frequency: 6 issues/year

PROGRESS IN CARDIOVASCULAR DISEASES is a leading journal in the field of cardiology and cardiovascular medicine, published by W B SAUNDERS CO-ELSEVIER INC. With an impressive impact factor that places it in the esteemed Q1 quartile of its category, this journal ranks among the top 32 out of 387 journals in its field, positioning itself in the 91st percentile. Since its inception in 1958 and continuing until 2024, it has been a prolific source of cutting-edge research, reviews, and clinical insights that contribute significantly to the understanding and treatment of cardiovascular diseases. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that all published content meets the highest standards of scientific excellence. As a key resource for researchers, practitioners, and students alike, PROGRESS IN CARDIOVASCULAR DISEASES serves as an indispensable tool for advancing knowledge and practice in cardiovascular health.

Clinica e Investigacion en Arteriosclerosis

Exploring innovative solutions in arterial disease management.
Publisher: ELSEVIERISSN: 0214-9168Frequency: 6 issues/year

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

Cardiovascular Innovations and Applications

Unlocking new horizons in cardiovascular health and treatment.
Publisher: COMPUSCRIPTISSN: 2009-8618Frequency: 1 issue/year

Cardiovascular Innovations and Applications is a premier open-access journal dedicated to advancing knowledge in the field of cardiovascular medicine. Published by COMPUSCRIPT since 2016, this journal provides a platform for the dissemination of innovative research and applications that address crucial topics in cardiology, aiming to bridge the gap between clinical practice and cutting-edge research. With an ISSN of 2009-8618 and an E-ISSN of 2009-8782, it operates on a global scale, facilitating access to high-quality content without financial barriers. The journal is positioned within the Medicine - Cardiology and Cardiovascular Medicine category, and its current Scopus rank of #321/387 reflects its potential for growth and influence in the academic community, being in the 17th percentile. Researchers, healthcare professionals, and students will find Cardiovascular Innovations and Applications an invaluable resource in their quest for the latest findings and advancements in cardiovascular health and treatment methodologies.

Arquivos Brasileiros de Cardiologia

Unveiling new horizons in cardiology through open access.
Publisher: ARQUIVOS BRASILEIROS CARDIOLOGIAISSN: 0066-782XFrequency: 12 issues/year

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

Journal of the Practice of Cardiovascular Sciences

Pioneering Insights for Cardiovascular Excellence
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2395-5414Frequency: 3 issues/year

Journal of the Practice of Cardiovascular Sciences, published by Wolters Kluwer Medknow Publications, is an esteemed Open Access journal dedicated to advancing knowledge in the field of cardiovascular health. With its ISSN 2395-5414 and E-ISSN 2454-2830, the journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality studies, innovations, and practical applications related to cardiovascular sciences. Established in 2015 as an Open Access journal, it promotes widespread sharing of insights to enhance cardiovascular practices and address contemporary challenges in the field. As part of a reputable publishing group, the journal is poised for growth and impact, contributing significantly to the ongoing dialogue in cardiovascular research and clinical practice.

HEART AND VESSELS

Fostering Knowledge for a Stronger Cardiovascular Future
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology

Unlocking the future of cardiovascular medicine.
Publisher: KARE PUBLISSN: 1016-5169Frequency: 8 issues/year

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology is a prominent peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. Published by KARE PUBL, this journal has established itself as a key resource for researchers, healthcare professionals, and students since its inception in 1990. As an Open Access journal since 2017, it ensures that cutting-edge research and clinical findings are readily accessible to a global audience, thus fostering collaboration and knowledge sharing among the cardiology community. With its recent rank in the Q3 quartile for Cardiology and Cardiovascular Medicine in 2023, and a Scopus rank of #282 out of 387, the journal is positioned to enhance its influence in the cardiovascular field, offering valuable insights and promoting evidence-based practices. The journal covers a wide range of topics within cardiology and cardiovascular research, making it an essential platform for scholars aiming to contribute to the ongoing dialogue in this vital area of medicine. For those eager to stay updated with the latest research trends and clinical practices in cardiology, Turk Kardiyoloji Dernegi Arsivi represents a crucial resource.